Larkspur Health Acquisition Corp. Contracts & Agreements

Form of Series A-2 Warrant (Filed With SEC on November 6, 2024)

Inducement Letter, dated November 5, 2024 (Filed With SEC on November 6, 2024)

Financial Advisory Agreement, dated November 5, 2024 (Filed With SEC on November 6, 2024)

Amended and Restated ZyVersa Therapeutics, Inc. 2022 Omnibus Equity Incentive Plan (Filed With SEC on October 30, 2024)

Sales Agreement dated September 16, 2024 by and between Zyversa Therapeutics, Inc., and A.G.P./Alliance Global Partners (Filed With SEC on September 16, 2024)

Form of Series A-1 Warrant (Filed With SEC on August 1, 2024)

Form of Series B-1 Warrant (Filed With SEC on August 1, 2024)

Inducement Letter, dated August 1, 2024 (Filed With SEC on August 1, 2024)

Financial Advisory Agreement, dated August 1, 2024 (Filed With SEC on August 1, 2024)

Description of the Companys Securities (Filed With SEC on March 25, 2024)

Form of Pre-Funded Warrant (Filed With SEC on December 11, 2023)

Form of Series A Common Warrant (Filed With SEC on December 11, 2023)

Form of Series B Common Warrant (Filed With SEC on December 11, 2023)

Form of Securities Purchase Agreement, dated as of December 6, 2023, between the Company and each purchaser named in the signature pages thereto (Filed With SEC on December 11, 2023)

Placement Agency Agreement, dated as of December 6, 2023, between the Company and A.G.P (Filed With SEC on December 11, 2023)

Form of Series A Common Warrant (Filed With SEC on December 6, 2023)

Form of Series B Common Warrant (Filed With SEC on December 6, 2023)

Form of Securities Purchase Agreement (Filed With SEC on December 6, 2023)

Form of Placement Agent Agreement (Filed With SEC on December 6, 2023)

Form of Pre-Funded Warrant (Filed With SEC on November 21, 2023)

Form of Common Warrant (Filed With SEC on November 21, 2023)

Form of Securities Purchase Agreement (Filed With SEC on November 21, 2023)

Form of Placement Agent Agreement (Filed With SEC on November 21, 2023)

Form of Lock-Up Agreement (Filed With SEC on November 21, 2023)

Form of Inducement Warrant (Filed With SEC on September 14, 2023)

Form of Inducement Letter (Filed With SEC on September 14, 2023)

Placement Agency Agreement (Filed With SEC on July 26, 2023)

Form of Placement Agency Agreement (Filed With SEC on July 7, 2023)

Form of Warrant in connection with this Offering (Filed With SEC on July 7, 2023)

Form of Pre-Funded Warrant in connection with this Offering (Filed With SEC on July 7, 2023)

Form of Securities Purchase Agreement (Filed With SEC on July 7, 2023)

Form of Placement Agency Agreement (Filed With SEC on June 30, 2023)

Form of Warrant in connection with this Offering (Filed With SEC on June 30, 2023)

Form of Pre-Funded Warrant in connection with this Offering (Filed With SEC on June 30, 2023)

Form of Securities Purchase Agreement (Filed With SEC on June 30, 2023)

Form of Placement Agency Agreement (Filed With SEC on April 18, 2023)

Form of Warrant in connection with this Offering (Filed With SEC on April 18, 2023)

Form of Pre-Funded Warrant in connection with this Offering (Filed With SEC on April 18, 2023)

Form of Securities Purchase Agreement (Filed With SEC on April 18, 2023)

Form of Escrow Agreement (Filed With SEC on April 18, 2023)

Description of the Companys Securities (Filed With SEC on March 31, 2023)

Amendment and Restatement Agreement, dated February 28, 2023, by and between ZyVersa Therapeutics, Inc. and L&F Research LLC (Filed With SEC on March 3, 2023)

Form of Placement Agency Agreement (Filed With SEC on February 13, 2023)

Form of Warrant in connection with this Offering (Filed With SEC on February 13, 2023)

Form of Pre-Funded Warrant in connection with this Offering (Filed With SEC on February 13, 2023)

Form of Securities Purchase Agreement (Filed With SEC on February 13, 2023)

Executive Employment Agreement, by and between the Company and Pablo Guzman, M.D (Filed With SEC on January 27, 2023)

Second Amendment to Waiver of Certain Rights under License Agreement (Filed With SEC on December 23, 2022)

Specimen Class A Common Stock Certificate of ZyVersa Therapeutics, Inc (Filed With SEC on December 13, 2022)

Form of Warrant issued by the Company to each PIPE Investor (Filed With SEC on December 13, 2022)

Form of Bridge Warrant issued by the Company (Filed With SEC on December 13, 2022)

Amended and Restated Registration Rights Agreement, dated as of December 12, 2022, by and among the Company and each of the purchasers identified on the signature pages thereto (Filed With SEC on December 13, 2022)

Registration Rights Agreement, relating to Series A Preferred Stock, dated as of December 12, 2022, by and among the Larkspur Health Acquisition Corp. and each of the PIPE... (Filed With SEC on December 13, 2022)

Registration Rights Agreement, relating to Series B Preferred Stock, dated as of December 12, 2022, by and among the Company and each purchaser identified on the signature pages... (Filed With SEC on December 13, 2022)

ZyVersa Therapeutics, Inc. 2022 Omnibus Incentive Plan (Filed With SEC on December 13, 2022)

Form of Indemnification Agreement by and between the Company and each of its officers and directors (Filed With SEC on December 13, 2022)

Executive Employment Agreement, by and between the Company and Stephen Glover (Filed With SEC on December 13, 2022)

Executive Employment Agreement, by and between the Company and Nicholas A. LaBella (Filed With SEC on December 13, 2022)

Executive Employment Agreement, by and between the Company and Karen A. Cashmere (Filed With SEC on December 13, 2022)

Executive Employment Agreement, by and between the Company and Peter Wolfe (Filed With SEC on December 13, 2022)

Amendment to Variant Pharmaceuticals, Inc. 2014 Equity Incentive Plan (Filed With SEC on December 13, 2022)

Business Combination Agreement, dated as of July 20, 2022 (as it may be amended and/or restated from time to time, the Business Combination Agreement), by and among Larkspur... (Filed With SEC on July 22, 2022)

Form of Warrant issued by the Registrant to each Private Placement Investor (Filed With SEC on July 22, 2022)

Securities Purchase Agreement, dated as of July 20, 2022, by and among Larkspur Health Acquisition Corp. and each purchaser identified on the signature pages thereto (Filed With SEC on July 22, 2022)

Form of Amended and Restated Registration Rights Agreement, by and among Larkspur Health Acquisition Corp. and each purchaser identified on the signature pages thereto (Filed With SEC on July 22, 2022)

Form of Shareholder Support Agreement, by and among Larkspur Health Acquisition Corp., ZyVersa Therapeutics, Inc. and certain of the stockholders of ZyVersa Therapeutics, Inc,... (Filed With SEC on July 22, 2022)

Form of Lock-Up Agreement, by and among Larkspur Health Acquisition Corp. and the parties listed on Schedule A thereto (Filed With SEC on July 22, 2022)

Description of Securities of the Registrant (Filed With SEC on April 15, 2022)

Underwriting Agreement, dated December 20, 2021, by and between the Company and A.G.P., as representative of the several underwriters named therein (Filed With SEC on December 23, 2021)

Business Combination Agreement, dated December 20, 2021, by and between the Company and A.G.P (Filed With SEC on December 23, 2021)

Warrant Agreement, dated December 20, 2021, by and between the Company and CST&T (Filed With SEC on December 23, 2021)

Letter Agreement, dated December 20, 2021, by and among the Company and its officers, directors, Sponsors, and the other parties named therein (Filed With SEC on December 23, 2021)

Investment Management Trust Agreement, dated December 20, 2021, by and between the Company and CST&T (Filed With SEC on December 23, 2021)

Registration Rights Agreement, dated December 20, 2021, by and among the Company and certain security holders of the Company (Filed With SEC on December 23, 2021)

Private Units Purchase Agreement, dated December 20, 2021, by and between the Company and Larkspur Health (Filed With SEC on December 23, 2021)

Private Units Purchase Agreement, dated December 20, 2021, by and between the Company and the Sponsor Investors (Filed With SEC on December 23, 2021)

Indemnity Agreement, dated December 20, 2021, by and between the Company and each of the officers and directors of the Company (Filed With SEC on December 23, 2021)

Form of Letter Agreement among the Registrant and our officers, directors and Larkspur Health LLC (Filed With SEC on December 7, 2021)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on December 7, 2021)

Side Letter between A.G.P./Alliance Global Partners and certain Additional Sponsor Investors (Filed With SEC on December 7, 2021)

Side Letter between Larkspur Health LLC and certain Additional Sponsor Investors (Filed With SEC on December 7, 2021)

Form of Private Units Purchase Agreement between the Registrant and the Additional Sponsor Investors (Filed With SEC on December 7, 2021)

Form of Underwriting Agreement (Filed With SEC on November 8, 2021)

Specimen Unit Certificate (Filed With SEC on November 8, 2021)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on November 8, 2021)

Form of Letter Agreement among the Registrant and our officers, directors and Larkspur Health LLC (Filed With SEC on November 8, 2021)

Amended and Restated Promissory Note, dated October 7, 2021, issued to Lakespur Holdings LLC (Filed With SEC on November 8, 2021)

Amended and Restated Promissory Note, dated October 7, 2021, issued to L1 Capital Global Opportunities Master Fund, Ltd (Filed With SEC on November 8, 2021)

Amended and Restated Promissory Note, dated October 7, 2021, issued to Daniel J. OConnor (Filed With SEC on November 8, 2021)

Amended and Restated Promissory Note, dated October 7, 2021, issued to S.H.N. Financial Investments Ltd (Filed With SEC on November 8, 2021)

Amended and Restated Promissory Note, dated October 7, 2021, issued to Mitchell Schiff (Filed With SEC on November 8, 2021)

Amended and Restated Promissory Note, dated October 7, 2021, issued to Jeffry Bernstein (Filed With SEC on November 8, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on November 8, 2021)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on November 8, 2021)

Form of Indemnity Agreement (Filed With SEC on November 8, 2021)

Agreement with Brio Financial Group (Filed With SEC on November 8, 2021)

Subscription Agreement, dated November 4, 2021, between the Registrant and Francis Knuettel II (Filed With SEC on November 8, 2021)

Form of Underwriting Agreement (Filed With SEC on September 17, 2021)

Business Combination Agreement (Filed With SEC on September 17, 2021)

Specimen Unit Certificate (Filed With SEC on September 17, 2021)

Specimen Class A Common Stock Certificate (Filed With SEC on September 17, 2021)

Specimen Warrant Certificate (Filed With SEC on September 17, 2021)

Form of Letter Agreement among the Registrant and our officers, directors and Larkspur Health LLC (Filed With SEC on September 17, 2021)

Promissory Note, dated May 7, 2021, issued to Lakespur Holdings LLC (Filed With SEC on September 17, 2021)

Promissory Note, dated May 7, 2021, issued to L1 Capital Global Opportunities Master Fund, Ltd (Filed With SEC on September 17, 2021)

Promissory Note, dated May 7, 2021, issued to Daniel J. OConnor (Filed With SEC on September 17, 2021)

Promissory Note, dated May 7, 2021, issued to S.H.N. Financial Investments Ltd (Filed With SEC on September 17, 2021)

Promissory Note, dated May 7, 2021, issued to Mitchell Schiff (Filed With SEC on September 17, 2021)

Promissory Note, dated May 7, 2021, issued to Jeffry Bernstein (Filed With SEC on September 17, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on September 17, 2021)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on September 17, 2021)

Subscription Agreement, dated May 7, 2021, between the Registrant and Larkspur Health LLC (Filed With SEC on September 17, 2021)

Subscription Agreement, dated May 7, 2021, between the Registrant and A.G.P./Alliance Global Partners (Filed With SEC on September 17, 2021)

Subscription Agreement, dated May 7, 2021, between the Registrant and Raj Mehra, Ph.D., J.D (Filed With SEC on September 17, 2021)

Subscription Agreement, dated May 7, 2021, between the Registrant and Gregory Skalicky (Filed With SEC on September 17, 2021)

Subscription Agreement, dated May 7, 2021, between the Registrant and Christopher Twitty, Ph.D (Filed With SEC on September 17, 2021)

Form of Private Units Purchase Agreement between the Registrant and Larkspur Health LLC (Filed With SEC on September 17, 2021)

Form of Indemnity Agreement (Filed With SEC on September 17, 2021)

Side Letter, dated September 11, 2021, between the Registrant and A.G.P./Alliance Global Partners (Filed With SEC on September 17, 2021)

Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on July 27, 2021)

Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on July 7, 2021)

Category

Industry

Companies

Contracts

Larkspur Health Acquisition Corp. Contracts & Agreements